Attainment of ldl-cholesterol goals is suboptimal with rosuvastatin monotherapy in us patients at high cardiovascular risk
Abstract
Authors
E. Marrett Q. Zhang C. Zhao D. Ramey D.R. Neff A.M. Tershakovec
E. Marrett Q. Zhang C. Zhao D. Ramey D.R. Neff A.M. Tershakovec
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now